Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Acceleron receives PRIME designation from EMA for Sotatercept in pulmonary arterial hypertension

pharmaceutical-business-reviewMay 06, 2020

Tag: Acceleron , sotatercept , pulmonary arterial hypertension , PRIME

PharmaSources Customer Service